粪便细菌疗法
生物
移植
粪便
临床试验
微生物学
重症监护医学
生物信息学
医学
内科学
抗生素
艰难梭菌
标识
DOI:10.1016/j.chom.2020.01.018
摘要
Fecal microbiota for transplantation (FMT) is being studied as a potential intervention for numerous conditions. The regulation of FMT by the FDA is discussed along with FMT donor screening and manufacturing considerations. The FDA is committed to ensuring that FMT products can be safely tested in clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI